Stay updated on Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Prostate cancer, MedlinePlus Genetics, and the related topics header, along with Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2026-01-14T01:21:29.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added related topics: Prostate cancer and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-01-06T22:53:08.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Locations section updated to include New York and Wisconsin as study sites. Location subsections were reorganized under a new Locations header.
    Difference
    0.3%
    Check dated 2025-12-23T09:45:43.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 instead of v3.3.1; there are no visible changes to the study details or layout.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:20.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.1. The change does not modify study details, eligibility criteria, or results information.
    Difference
    0.1%
    Check dated 2025-11-24T13:07:40.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Removed a general government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:25:26.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.